Can treating an upper respiratory tract infection (URTI) prevent acute rheumatic fever, post‑streptococcal glomerulonephritis (PSGN), or IgA‑mediated renal complications?

Treating Streptococcal Pharyngitis Prevents Rheumatic Fever but NOT Post-Streptococcal Glomerulonephritis or IgA Nephropathy

Adequate antibiotic treatment of group A streptococcal (GAS) pharyngitis effectively prevents acute rheumatic fever, but does NOT prevent post-streptococcal glomerulonephritis (PSGN), and has no relationship to IgA nephropathy complications. 1, 2

Rheumatic Fever: Prevention Works

The evidence is unequivocal that treating streptococcal pharyngitis prevents rheumatic fever:

• Primary prevention of acute rheumatic fever is accomplished by proper identification and adequate antibiotic treatment of GAS tonsillopharyngitis 1
• Treatment can be started up to 9 days after symptom onset and still effectively prevent rheumatic fever 1
• Penicillin (oral penicillin V or intramuscular benzathine penicillin G) remains the treatment of choice 1, 2
• The mechanism works because adequate antibiotic therapy eradicates the streptococcal infection before the autoimmune cascade leading to rheumatic fever is fully established

Clinical Pearl: Even a 24-48 hour delay to process throat culture does not increase rheumatic fever risk, so waiting for culture confirmation before starting antibiotics is safe and appropriate 1

Post-Streptococcal Glomerulonephritis: Treatment Does NOT Prevent

This is a critical distinction that many clinicians miss:

• Expedient antimicrobial treatment of GAS pharyngitis does NOT prevent acute post-streptococcal glomerulonephritis 3
• PSGN develops through immune complex deposition in glomeruli, a process that occurs regardless of antibiotic treatment timing 4, 5
• The only animal model showing prevention required penicillin within the first 3 days of infection 6, but this has never been demonstrated in human clinical practice
• The main way to prevent PSGN is to treat GAS infections to prevent the initial infection from occurring, not to prevent PSGN after infection has already started 4

The pathophysiology explains why: PSGN results from immune complex formation and complement activation that begins during the acute infection phase, before most patients even seek medical care 5. By the time pharyngitis is diagnosed, the immunologic cascade is already underway.

IgA Nephropathy: No Relationship to Streptococcal Treatment

IgA nephropathy is a completely separate entity:

• IgA nephropathy presents with synpharyngitic hematuria (hematuria concurrent with upper respiratory infections), but this is NOT caused by streptococcal infection 7
• IgA nephropathy is a chronic immune-mediated glomerular disease involving IgA-containing immune complex deposition, unrelated to GAS infection 7
• The temporal association with URTIs is coincidental—the mucosal immune response triggers IgA production, but treating the URTI does not prevent or modify IgA nephropathy
• Treatment focuses on immunosuppression (targeted-release budesonide, glucocorticoids, iptacopan) and nephroprotection (RAAS inhibitors, SGLT2 inhibitors), not antibiotics 7

Common Pitfall to Avoid

Do not withhold or delay appropriate antibiotic treatment for confirmed GAS pharyngitis based on concerns about PSGN. While antibiotics won't prevent PSGN, they remain essential for:

• Preventing rheumatic fever (the primary goal) 1, 2
• Reducing symptom duration and severity 2
• Decreasing contagiousness and transmission 2
• Preventing suppurative complications (peritonsillar abscess, cervical lymphadenitis) 2

Clinical Algorithm for URTI Management

When evaluating a patient with pharyngitis:

1. Confirm GAS infection via rapid antigen test or throat culture 1, 2
2. If GAS positive: Treat with penicillin V 500mg BID-TID × 10 days (or benzathine penicillin G IM × 1 for adherence concerns) 1
3. Monitor for rheumatic fever prevention (this is your primary goal)
4. Do NOT expect PSGN prevention from antibiotic treatment
5. If hematuria develops 1-3 weeks post-infection: Evaluate for PSGN with urinalysis, complement levels, and ASO titers 5
6. If recurrent hematuria with URTIs: Consider IgA nephropathy, which requires kidney biopsy for diagnosis 7

The distinction matters for patient counseling: you can confidently tell patients that antibiotics will prevent rheumatic fever, but you must explain that kidney complications (PSGN) may still occur despite appropriate treatment.